Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest Clinical Trials & Medical Discoveries

04 Jan, 2018, 10:25 GMT Alligator Bioscience to Present at the 10th Annual Biotech Showcase Conference

Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company developing tumor-directed immunotherapies, today announced that the...


04 Jan, 2018, 09:22 GMT Cantargia Receives Notice of Allowance From USPTO for Expanded Protection in Treatment of Solid Tumours

Cantargia AB ("Cantargia") has been notified that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for the...


04 Jan, 2018, 09:00 GMT Hycor Biomedical Applies CE Mark to IVD Allergy Instrument: NOVEOS™

Hycor Biomedical, a leading manufacturer of in vitro diagnostic products for allergy and autoimmune testing, announced today that it has applied...


04 Jan, 2018, 08:00 GMT Acacia Pharma Announces FDA Acceptance of NDA Filing For BAREMSIS® for the Management of Post-operative Nausea & Vomiting

If approved, BAREMSIS would be the first antiemetic with an indication for: - rescue treatment of PONV after failed prophylaxis, and -...


04 Jan, 2018, 08:00 GMT Heptares Scientists Solve Structure of Complement C5a Receptor, an Important Drug Target for Inflammatory and Neurodegenerative Diseases, and Cancer

Publication in Nature highlights opportunities to target C5a receptor with selective small molecules via novel mechanism of action Sosei Group...


04 Jan, 2018, 02:24 GMT Glucagon Receptor Structure Offers New Opportunities for Type 2 Diabetes Drug Discovery

- Complex structure of a class B GPCR bound to an analogue of its endogenous ligand ignites new excitement in GPCR research Class B G...


04 Jan, 2018, 00:00 GMT BlueWind Medical Announces the Publication of Breakthrough Results for BLUEWIND-RENOVA™ Implantable Tibial Nerve Neuromodulator

6-Month OPTIMIST Study show BlueWind Renova™ is a safe, minimally invasive system that offers significant improvements for Over Active...


03 Jan, 2018, 14:00 GMT Diagnosing, Treating Sleep Apnea in Hospital Improves Survival, Says Study Published by American Journal of Medicine

Undiagnosed sleep apnea is highly prevalent among hospital patients, and treating it after they're discharged can improve their chances of...


03 Jan, 2018, 12:36 GMT PharmaMar has Requested the Process of Re-Examination for Aplidin® from the EMA

PharmaMar (MCE: PHM) has announced the initiation of the re-examination process by the European Medicines Agency (EMA) for Aplidin® (plitidepsin)...


03 Jan, 2018, 08:00 GMT PlaqueTec Announces First Peer-Reviewed Publication for its Liquid Biopsy System™ (LBS)

Article in JACC: Basic to Translational Science Validates Feasibility and Unique Potential of LBS to Detect Biomarkers for Coronary Artery...


29 Dec, 2017, 12:00 GMT GW Pharmaceuticals Submits Marketing Authorisation Application in Europe for Epidiolex® (cannabidiol) in the Treatment of Lennox-Gastaut Syndrome and Dravet Syndrome

GW Pharmaceuticals plc (Nasdaq: GWPH, "GW" or "the Company"), a biopharmaceutical company focused on discovering, developing and commercializing...


27 Dec, 2017, 07:29 GMT Test For AKI Risk Assessment Could Lead To Safer ICU Care

Astute Medical Says New Study Shows NephroCheck Test Can Expose Risk of AKI Stemming From Nephrotoxic Antibiotics and Other Renal Insults....


22 Dec, 2017, 07:00 GMT NightBalance Obtains Reimbursement in the Netherlands for its Innovative Sleep Apnea Therapy

The Sleep Position Trainer (SPT®), developed by NightBalance, treats Positional Obstructive Sleep Apnea (POSA) which affects half a million...


21 Dec, 2017, 13:59 GMT Xspray Pharma Enters Manufacturing Agreement With NerPharMa for its Lead Product Candidate - HyNap-Dasa

Xspray Pharma AB, a specialty pharmaceutical company, today announced that it has signed a Manufacturing and Supply Agreement with NerPharMa...


21 Dec, 2017, 13:30 GMT Jazz Pharmaceuticals Submits New Drug Application for Solriamfetol (JZP-110) for Excessive Sleepiness Associated with Narcolepsy and Obstructive Sleep Apnea

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration on...


21 Dec, 2017, 10:04 GMT First Publication of HemaSphere, the New Journal of the European Hematology Association, Now Online

HemaSphere, the new open access journal of the European Hematology Association (EHA),was published on December 20. HemaSphere is an open...


20 Dec, 2017, 18:29 GMT JHL Biotech Submits Clinical Trial Application in Europe for Proposed Dornase Alfa Biosimilar to Affordably Manage Symptoms of Cystic Fibrosis

JHL Biotech (Stock Code: 6540.TWO) announced today that it has submitted a Phase 1 Clinical Trial Application to the Dutch Healthcare Authority for...


20 Dec, 2017, 18:00 GMT New Research Demonstrates Direct Link between Inflammasome Activation and Amyloid-β Pathology in Alzheimer's Disease

Study published in Nature by IFM Therapeutics scientific co-founder Dr. Eicke Latz and clinical advisory board member Dr. Michael Heneka...


20 Dec, 2017, 15:35 GMT JHL Biotech Submits Clinical Trial Application in Europe for Proposed Bevacizumab Biosimilar to Treat Colorectal, Lung, and Ovarian Cancers

JHL Biotech Inc. (Stock Code: 6540.TWO) announced that it submitted a Phase I Clinical Trial Application on December 15, 2017 to European...


19 Dec, 2017, 13:45 GMT NRGene Delivers First-ever Food Potato Genomes

NRGene, the worldwide leader in genomic assembly and analysis, is working with a team of researchers from Wageningen University & Research...


15 Dec, 2017, 13:30 GMT Ultragenyx and Kyowa Kirin Announce Burosumab Receives Positive CHMP Opinion for the Treatment of X-Linked Hypophosphatemia in Children

If approved, burosumab would be the first targeted disease-modifying treatment for XLH Kyowa Hakko Kirin Co., Ltd. (Kyowa Hakko Kirin), Kyowa...


15 Dec, 2017, 11:34 GMT Swedish Cell Therapy Candidate CellProtect has Received Orphan Drug Designation for the Treatment of Multiple Myeloma

CellProtect Nordic Pharmaceuticals AB ('CPNP') has been notified by the European Commission that its cell therapy candidate CellProtect has...


13 Dec, 2017, 16:04 GMT Eurocine Vaccines Challenges the Flu

While Australia has faced one of the harshest influenza seasons of decades[1], Eurocine Vaccines prepares for the next phase of development, a...


12 Dec, 2017, 15:56 GMT AXON Meets the First Milestone in an nfvPPA Phase 1 Study With AADvac1

AXON has announced the initiation of open recruitment in the currently running Phase 1 study in patients suffering from the non-fluent variant...


12 Dec, 2017, 15:41 GMT New European real-world audit data provides additional information on the effectiveness of Zebinix® (eslicarbazepine acetate) for the treatment of partial-onset epilepsy in adults

- Results from the pooled analysis presented at the American Epilepsy Society Annual Meeting 2017 in Washington DC, US.[1],[2],[3]...